SCHEMBL4479814

SCHEMBL4479814

CCCc1cc2c(c(O)n1)C(=O)OCC2

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
BACE1 P56817 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
GAA P10253 2/20 0.34
PKM P14618 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
PGR P06401 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP1A2 P05177 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4247622 0.99 MAOA (0.35) MAOAMAOBBACE1L3MBTL1GAA
SCHEMBL4749132 0.89 MAOA (0.37) MAOAMAOBGAAKMT2AKDM4E
SCHEMBL4071256 0.84 MAPT (0.36) BACE1L3MBTL1PKMKMT2AALDH1A1
SCHEMBL4072001 0.83 BACE1 (0.40) MAOAMAOBBACE1L3MBTL1GAA
SCHEMBL4788071 0.80 PGR (0.43) L3MBTL1PKMKMT2AALDH1A1KDM4E
SCHEMBL4247127 0.80 KDM4E (0.47) L3MBTL1PKMKMT2AALDH1A1KDM4E
SCHEMBL4066514 0.78 GAA (0.43) MAOAMAOBL3MBTL1GAAKMT2A
SCHEMBL4749400 0.78 MAOA (0.35) MAOAMAOBGAAKMT2ATAAR1
SCHEMBL4072219 0.77 MAOA (0.38) MAOAMAOBL3MBTL1GAAKMT2A
SCHEMBL4069470 0.77 MAOA (0.37) MAOAMAOBGAAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601736-B2 Such as 3,4-dihydro-pyrano[3,4-c]pyridine-1-on; cytokine suppressive antiinflammatory drugs; analgesics SK CHEMICALS CO., LTD. (KR) 2009-10-13 US claimed
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same SK CHEMICALS CO., LTD. (KR) 2007-11-01 US claimed
US-7601736-B2 Such as 3,4-dihydro-pyrano[3,4-c]pyridine-1-on; cytokine suppressive antiinflammatory drugs; analgesics SK CHEMICALS CO., LTD. (KR) 2009-10-13 US disclosed
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same SK CHEMICALS CO., LTD. (KR) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same IL5, IL1B, P2RY4 MAOA 662/4885MAOB 760/4885BACE1 3981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.